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Abstract
Background Functional recovery of arm movement typically plateaus following a stroke,
leaving chronic motor deﬁcits. Brain-computer interfaces (BCI) may be a potential treatment
for post-stroke deﬁcits
Methods In this n-of-1 trial (NCT03913286), a person with chronic subcortical stroke with
upper-limb motor impairment used a powered elbow-wrist-hand orthosis that opened and
closed the affected hand using cortical activity, recorded from a percutaneous BCI comprised
of four microelectrode arrays implanted in the ipsilesional precentral gyrus, based on
decoding of spiking patterns and high frequency ﬁeld potentials generated by imagined hand
movements. The system was evaluated in a home setting for 12 weeks
Results Robust single unit activity, modulating with attempted or imagined movement, was
present throughout the precentral gyrus. The participant acquired voluntary control over a
hand-orthosis, achieving 10 points on the Action Research Arm Test using the BCI, compared
to 0 without any device, and 5 using myoelectric control. Strength, spasticity, the Fugl-Meyer
scores improved.
Conclusions We demonstrate in a human being that ensembles of individual neurons in the
cortex overlying a chronic supratentorial, subcortical stroke remain active and engaged in
motor representation and planning and can be used to electrically bypass the stroke and
promote limb function. The participant’s ability to rapidly acquire control over otherwise
paralyzed hand opening, more than 18 months after a stroke, may justify development of a
fully implanted movement restoration system to expand the utility of fully implantable BCI to
a clinical population that numbers in the tens of millions worldwide.

Plain language summary
Stroke is a restriction of blood ﬂow to
part of the brain and can lead to
chronic issues with a person’s ability
to control the limbs. The aim of this
study was to see if a new type of
device could restore movement in a
person with arm weakness due to a
stroke that occurred a year earlier. In
our trial, a sensor was implanted into
the surface of the brain, near the site
of the stroke, and was connected to a
computer that generated a command
to open and close the hand with a
motorized brace worn on the hand.
This person was able to use their own
brain activity to trigger the brace and
pick up and move objects. This
research could support the development of similar medical devices to
restore movement in people who
have had strokes.
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troke is a leading cause of disability1 with a global prevalence of over 42 million people in 20152, affecting over
four million adults in the United States alone with 800,000
new cases per year3. Stroke leads to permanent motor disabilities
in 80% of cases4, and half of stroke survivors require long term
care. Brain computer interface (BCI) technologies offer a potential solution to restore functional independence and improve
health in people living with its effects. In the past decade, intracortical BCI technology has continued to advance, with multiple
groups demonstrating the safety and efﬁcacy of this approach to
derive control signals5–7 to restore communication and control.
In parallel, wearable robotic orthosis technology can beneﬁt
patients with weakened limbs8,9. This single-patient pilot clinical
trial sought to prove that a commercially available powered arm
orthosis could be linked to the cerebral cortex in an adult with the
most common form of chronic stroke. A direct path from the
brain’s motor centers to the orthotic could reanimate a paralyzed
limb to enable useful hand and arm function.
Several signal sources have been coopted to provide commands
to move paralyzed limbs. Electromyographic (EMG) control of a
powered orthosis or functional electrical stimulation (FES) of
muscles, has proven problematic either because users could not
generate sufﬁcient or reliable activity to provide a good control
signal, or because voluntary activation of those recorded muscles
(that were intended to generate the command) was opposed by
the stimulator’s effects10. Contralaterally controlled electrical
stimulation- where activity from the unaffected arm triggers stimulation on the paretic arm- is a useful therapeutic intervention
to improve function in the weaker limb11 but it is not clear how
this unnatural command source could be generalized to
continuously-worn devices that enable independent arm movements. Several groups have explored scalp EEG, which is closer to
the command’s origins, to derive control signals to drive robotic
braces, and in one case, FES8,10,12,13. While using EEG-derived
signals may be promising for rehabilitation therapy, it would not
be feasible for daily independent function because skin sweat and
hair can cause impedances to ﬂuctuate, compromising signal
quality. Daily application of even a subset of contacts to the same
skin sites can lead to skin breakdown and cellulitis. Further, EEG
signals are limited in the commands that can be easily and reliably derived from the available signal. By contrast, intracortical
interfaces offer a rich source of high resolution, multidimensional
control signals, since it is the origin of such signals in healthy
adults, in non-human primates and in people with spinal or
brainstem disorders7,14,15.
While most strokes involve cerebral white matter and direct
parenchymal damage, intracortical neuromotor prosthetics have
not been tested in people with strokes above the mesencephalon.
It is not known whether motor cortex remains a reliable signal
source in this large population. A proof-of-concept that a braincomputer interface, based on micro-electrode arrays implanted in
intact cortex above a subcortical stroke, could restore behaviorally
useful independent, voluntary movement, could lead to the

development of a fully implantable medical device that, in principle, could reverse the motor deﬁcits caused by stroke. The
purpose of this study was to show whether an assistive braincomputer interface, when in use, could provide a behaviorally
useful beneﬁt in motor function.
Here we found that neural activity recorded from the cerebral
cortex overlying a chronic, subcortical stroke, generated activity
patterns related to both actual and imagined movements in the
contralateral, weakened limb of a person. The recorded neural
activity was decoded in real-time to control a motor on a brace
worn on the weakened arm, and the participant was able to use
this decoded signal to voluntarily open and close the hand to
perform tasks in a home setting.
Methods
Approval for this study was granted by the US Food and Drug
Administration (Investigational Device Exemption) and the
Thomas Jefferson University Institutional Review Board (protocol
number 17D.459). The participant described in this report has
provided permission for photographs, videos and portions of his
protected health information to be published for scientiﬁc and
educational purposes. After completion of informed consent on
March 4, 2020, medical and surgical screening procedures, two
MultiPorts (Blackrock Microsystems, UT), each comprising two
8 × 8 platinum tipped microelectrode arrays tethered to a titanium pedestal connector, were implanted into the cortex of the
precentral gyrus using a pneumatic insertion technique16,17.
Details of the human surgical procedure are in preparation for
publication and followed other similar studies. Trial selection
criteria are available online (see Clinicaltrials.gov, NCT03913286
and Supplementary Table 1). The trial was designed with the
implantation phase to last a maximum of three months (Fig. 1).
Participant. The participant was a right-handed male who
experienced right hemispheric stroke, manifest as acute onset
dense left hemiparesis and expressive aphasia, at which time he
was age between ages 35 and 40. Due to unknown time of onset
and hypertension at presentation, the participant was not a
candidate for thrombolysis. CT angiogram showed occlusion of
the right posterior cerebral artery and high-grade stenosis of the
left posterior cerebral artery in the proximal P2 segment. MRI of
the brain showed acute infarcts in the right basal ganglia/corona
radiata and right occipital lobe. He was started on dual antiplatelet therapy for 3 weeks and then was transitioned to aspirin
81 mg once daily, along with atorvastatin and anti-hypertensives.
He had left-sided hemiparesis, dysphagia, left homonymous
hemianopsia and dense left visual neglect and was transferred for
inpatient rehabilitation. Over a period of three months, aphasia
and dysphagia resolved and he learned to ambulate independently, albeit with a persistent left foot drop. Neuroimaging
showed evidence of multi-focal strokes, and prior silent strokes.
The participant had previously been in good health and did not
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Fig. 1 The clinical trial timeline. This ﬁgure shows the sequence of the Cortimo clinical trial.
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have any known stroke risk factors such as diabetes or smoking.
There was a history of loud snoring and the participant had not
been evaluated for obstructive sleep apnea. Transthoracic and
transesophageal echocardiography were normal as were serial
hypercoagulability panels; the participant was adopted and the
biological family history unknown. The participant was deemed
to have had embolic strokes of unknown source. Although serial
electrocardiography since the stroke was normal, the participant
is being scheduled for a loop recorder to survey for possible
paroxysmal atrial ﬁbrillation. The participant had learning disabilities and was presumed to have had mild cognitive impairment prior to the stroke. Screening formal neuropsychological
testing identiﬁed neurocognitive problems (full scale IQ 59) and
concluded that the participant remained fully capable to provide
proper informed consent and to participate in this trial, meeting
its demands and requirements. The participant provided both
verbal and written informed consent, both to participate in the
trial and to share his identifying information with the public. He
had been working full time at the time of the stroke and has been
unable to return to work since the stroke. Clinical assessment of
the participant included neurological exams one year, six months
and one month prior to enrollment in the setting of routine
outpatient care; the exam was serially repeated once enrolled.
Clinical assessment included detailed history review and conﬁrmation of meeting all selection criteria. The trial was constructed to include a six-week screening phase (Fig. 1), during
which the participant underwent occupational therapy (1 h
per session, three times per week) to assess how well the participant could understand and master use of the MyoPro device.
The neuropsychological testing also took place during the
screening phase. Predeﬁned outcome measures (described subsequently) were also recorded during the screening phase. During
this phase, therapy consisted of evaluation of active and passive
range of motion, strength, hypertonicity, and goal setting with
ADLs and IADLs. Treatment of left upper extremity spasticity
was completed utilizing stretching, functional electrical stimulation, and creating a splinting schedule. This pre-implant occupational therapy was considered screening in that it was decided
prior to enrolling the participant that proceeding to implant
would only occur if the occupational therapist felt that the participant could adequately comply with the therapy. Therapeutic
exercise and activity were incorporated to improve postural
control and non-volitional movements with left upper extremity.
Introductory use of MyoPro device was incorporated within
treatment. Pre-implant physical therapy included baseline functional balance measures with interventions focused on open/
closed chain strengthening, static/anticipatory/dynamic postural
control and gait training.

instructed to follow the movements in the video or concentrate
on following for the paretic limb. Task prioritization was based
on pre-exam training of the participant’s capabilities and examination of BOLD activation observed during the scan. Post processing including motion correction, smoothing, and general
linear model estimation performed using SPM software
(www.ﬁl.ion.ucl.ac.uk/spm) and Nordic brain EX software
(NordicNeuroLab, Bergen, Norway). Statistical maps were overlaid on the 3D T2 FLAIR image for visualization of activation.
Cortimo system. ‘Cortimo’ is the designation provided to the
FDA to represent the overall system (Fig. 2) that comprised two
percutaneous Multiports (Blackrock Microsystems), each in turn
having two multi-electrode array sensors, the cabling, ampliﬁers,
software and the powered MyoPro orthosis. Each sensor is an
8 × 8 array of silicon microelectrodes that protrude 1.5 mm from
a 3.3 × 3.3-mm platform. At manufacture, electrodes had an
impedance ranging between 70 KOhm and 340 KOhm. The
arrays were implanted onto the surface of the MI arm/hand
region guided by the pre-operative fMRI; with electrodes penetrating the cortex to attempt to record neurons in layer V.
Recorded electrical signals pass externally through a Ti percutaneous connector secured to the skull. Cabling attached to the
connector during recording sessions routes signals to external
ampliﬁers and a computer that process the signals and convert
them into different outputs, such as servo motor position of the
MyoPro brace or screen position of a neural cursor. Currently,
this system must be set up and managed by an experienced
technician.
MyoPro brace. The MyoPro (Myomo, Inc, Cambridge, MA) is an
FDA-cleared myoelectric powered arm orthosis designed to
support a paretic arm9. The rigid brace incorporates metal contacts attached to soft straps that can be adjusted such that contacts rest on the biceps and triceps proximally, and on wrist
ﬂexors and extensors distally, on the paretic upper extremity. The
sensors continuously record the root mean square of underlying
muscle activity. Thresholds are manually set such that signals
exceeding them will trigger one of the MyoPro motors. Because
the participant retained residual elbow ﬂexion and extension
strength, the motor at the elbow was set up such that biceps
activation triggered elbow ﬂexion and triceps activation triggered
elbow extension. For hand opening, the MyoPro was set up to
either use myoelectric control, or to use BCI-based control. Since
the participant was unable to voluntarily extend the wrist or open
Patient cable
Recording array

Pre-operative fMRI. The participant underwent MRI on a 3 T
Philips Ingenia MRI scanner. A 1 mm isotropic 3-D T2 FLAIR
was obtained for structural localization. A single shot echoplanar
gradient echo imaging sequence with 80 volumes, repetition time
(TR) = 2 s, echo time (TE) = 25 msec, voxel size = 3 × 3 mm2,
slice thickness = 3 mm, axial slices = 37. The participant was
asked to visualize movements of his paretic left hand during the
MRI. Each motor trial consisted of a block design featuring a 20 s
rest block and a 20 s active block repeated. This block design was
repeated between 4 times for a total of 240 s scans. Visual stimuli
comprised a 20 s video depicting a 3D modeled limb at rest,
followed by a 20 s video of the limb performing the desired task.
Motor tasks included repeated hand open/clench or arm extension elbow and were either active (participant performed or
attempted to perform motion) or passive (physician manually
moved participant’s arm). In active tasks, the participant was

Decoder

Bluetooth communication

Powered arm orthosis

Fig. 2 The cortimo system. The overall device comprises two Multiports,
each with two 8 × 8 microelectrode arrays, patient cables linked to external
ampliﬁers, a decoding computer and a wearable, powered arm orthosis.
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the ﬁngers, the myoelectric mode was set up such that the default
state was with the hand open, and it would only be closed by
activating enough wrist ﬂexor activity.
MyoPro EMG control. The MyoPro device is designed to use
four EMG channels to achieve control user’s control over two
electric motors that control hand and elbow motion. The four
EMG channels are ﬁxed and they are: (1) forearm extensors; (2)
forearm ﬂexors; (3) triceps; and, (4) biceps. It is important
noticing that the MyoPro does not use raw EMG signals for hand/
elbow control mechanisms, but it calculates in real-time the
rectiﬁed RMS of the raw EMG signals and the RMS signals are
eventually compared against the user selected thresholds for
motion classiﬁcation.
Depending on the control mode selected, a combination of the
above channels can be used to control either a single joint at a
time or both. Namely, the available modes are dual mode, open
mode or close mode. In dual mode, hand motion controlled by
two manually set thresholds based on forearm EMGs. Elbow
motion controlled by two different manually set thresholds based
on biceps’ and triceps’ EMGs. The dual mode control principle is
as described in the eq. below:
8
Open; jFlexorst < FlexTh AND Extensorst > ExtTh
>
>
>
>
>
>
< Hold; jðFlexorst < FlexTh OR Extensorst < ExtThÞ
OR
Motion Type ¼
>
>
>
>
FlexTh
OR
Extensorst > ExtThÞ
ðFlexors
>
t
>
>
:
Close; jFlexorst > FlexTh AND Extensorst < ExtTh

ð1Þ
MyoPro DUAL Mode Motion Control Strategy: In DUAL mode
the MyoPro uses ﬂexors and extensors for each of the two joints
(hand and elbow) and two thresholds for motion control decision
making.
In open mode, hand motion controlled by one manually set
threshold based on forearm extensors. Elbow motion controlled
by one different manually set threshold based on triceps EMGs.
The open mode control principle is as described in the eq. below:

Open; Extensorst > ExtTh
ð2Þ
Motion Type ¼
Close; Extensorst < ExtTh
MyoPro OPEN Mode Motion Control Strategy: In OPEN mode
the MyoPro moves the joint into full ﬂexion if the extensors are
below the extension threshold while the joint is moved into full
extension if extensors are above the extensor threshold.
In close mode, hand motion controlled by one manually set
threshold based on forearm ﬂexors. Elbow motion controlled by
one different manually set threshold based on biceps. The close
mode control principle is as described in the eq. below:

Close; Flexorst > FlexTh
ð3Þ
Motion Type ¼
Open; Flexorst < FlexTh
MyoPro CLOSE Mode Motion Control Strategy: In CLOSE mode
the MyoPro moves the joint into full extension if the ﬂexors are
below the ﬂexion threshold while the joint is moved into full
ﬂexion if extensors are above the ﬂexion threshold. where Flexors
and Extensors are the corresponding EMG signals and ExtTh and
FlexTh are respectively manually set thresholds for extensors and
ﬂexors.
Pre-speciﬁed outcome measures. More than a year prior to
enrolling the participant, the trial was designed to assess speciﬁc
outcome measures one month prior to device implantation, and
again three months post-implantation. These metrics included
the Fugl-Meyer Motor Impairment Score18, the Action Research
4

Arm Test (ARAT)19, the Motricity Index20, the Hand and
Recovery Scales within the Stroke Impact Scale21. Although the
Giving Them A Hand scale22 was initially included as a metric on
the original IDE and IRB ﬁlings, the occupational therapist coinvestigators who subsequently joined the team felt that this was
not a well-validated measure and it was decided, prior to enrolling the participant, that it would not be used. During the implant
phase, a component of the Jebsen-Taylor measure (picking up,
moving and putting down ﬁve objects, one at a time, one after the
other)23 was added because it was found that the participant was
able to perform this task more consistently and easily with the
orthosis than the ARAT, inspiring greater participant motivation
and engagement and hence facilitating comparison of myoelectric
vs BCI control modes. The outcome measures were performed by
clinicians who were trained and standardized in administration,
and each measure was assigned to speciﬁc co-investigators to
perform serially to minimize inter-rater variability across time.
Recording sessions. Research sessions were scheduled ﬁve days
per week at a temporary residence, adjacent to the hospital,
provided to the participant. Sessions could be canceled or ended
early at the participant’s request. Sessions would commence with
neural recording and spike discrimination. While initial sessions
included ﬁlter building and structured clinical endpoint (cursor
control) trials, in the ﬁnal month of the trial, training-less algorithms were used with the participant proceeding directly to BCIcontrolled hand action once patient cables were connected. Performance of computer tasks, orthosis control and occupational
therapy exercises followed. The electrodes and neural signals
selected immediately before ﬁlter building remained constant for
any given session’s orthosis control trials.
Decoder ﬁlter building. Units were extracted using an automatic
thresholding approach based for each electrode channel, based on
Root Mean Squared multipliers15. For each session, single and
multiunit data or high frequency (100–1000 Hz) local ﬁeld
potentials derived from multiple channels (20–30) were used to
create a linear ﬁlter to convert these real-time multidimensional
neural features into either a one or a two-dimensional (position
or velocity) output signal. Motor activity and motor imagery
approaches were tested for ﬁlter building, including imagining
opening and closing the paretic hand, passively ﬂexing and
extending the elbow, passively opening and closing the hand, and
observing a computer cursor displayed on a monitor moving up
and down without any speciﬁc instruction. Training data for
building the linear ﬁlter were collected with the participant gazing
at a screen where a target cursor was moved slowly up and down
for one minute (5 s to go from the top to the bottom of the screen
or vice versa, at 20° visual angle). After this preliminary ﬁlter was
built (see next section for more details), a new 1-minute retraining session was performed, this time the manually controlled
target cursor was accompanied by a prediction cursor that was
neurally controlled by the participant. Using this additional
training set, a second ﬁlter was built and then tested on a simple
target acquisition game in which the y-position of the predicted
output was discretized into zones such that positions on the
upper part of the screen would cause an animation sprite to move
up by a ﬁxed distance (1 cm), and positions on the lower part of
the screen would cause the sprite to move down by the same ﬁxed
distance.
Decoder design. The Cortimo system has been designed to
provide a series of real-time decoding methods. Namely, two
types of decoders have been implemented both discrete and
continuous (i.e., ﬁlters). The available discrete classiﬁers were
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Linear Discriminant Analysis (LDA), Decision Trees, Support
Vector Machine (SVM), k-nearest neighbors (KNN); while the
available continuous decoders were: a position-velocity Kalman
ﬁlter24 and a linear ﬁlter25. All decoders could be quickly trained
using data and labels recorded during training sessions (ﬁlter
building sessions). The Cortimo participant and the BCI system
achieved the best brace control performance when the linear ﬁlter
was used and the training sessions were guided by a one or a twodimensional cursor control task. Brieﬂy, a cursor was displayed
on the computer screen and the cursor position was controlled
using a weighted linear combination of (ad-hoc) selected features
derived from real-time participant’s brain activity. The neural
features mostly used in this trial were either the cumulative
(across all selected channels) spike count binned in 200 ms
windows or the cumulative (across all selected channels) spectral
density of Local Field Potentials (LFPs) calculated in the frequency range 100–500 Hz with 50 Hz frequency steps.
To achieve better and more reliable brace control in closedloop tasks, the continuous (linear) ﬁlter output, originally
corresponding to a speciﬁc screen location, was fed into a
discretization block where the decision-making rules were either:

Extension; xt < AT
ð4Þ
PBM t ¼
Flexion; xt ≥ AT
The Cortimo Discretization Block: Discretization decision rule
number 1. where PBMt represents the hand motion at time step t,
xt is the linear ﬁlter output at time step t and AT is a position
threshold chosen to maximize user’s control.
8
< Extension; xt < AT 1
ð5Þ
PBM t ¼
Hold; AT 2 < xt ≥ AT 1
:
Flexion; xt ≥ AT 2
The Cortimo Discretization Block: Discretization decision rule
number 2. where PBMt represents the hand motion at time step t,
xt is the linear ﬁlter output at time step t and AT and AT2 are
respectively a lower and higher position thresholds chosen to
maximize user’s control.
BCI orthosis use. The discrete output was then used to control
the aperture of the hand via the MyoPro’s hand brace motor. The
up-down mapping on the screen was translated into closed-open
positions of the hand. The participant then performed a series of
functional tasks including grasping and then dropping an object,
the Action Research Arm Test19, and a variation on Jebsen Taylor
item moving test23. These were tested with both the participant
seated and standing.
Training-less mapping. When the participant would attempt to
overpower the orthosis motors with residual ﬁnger ﬂexion
strength, a ‘training-less’ approach was invented and deployed in
which a rolling 1-second baseline of the LFPs signals was used to
calculate spectral power in the high gamma band (100–500 Hz).
Namely, 1-second long LFP continuous voltages were used for
computing the average spectral density estimation in the frequency band 100–500 Hz, using non-overlapping frequency bins
with a 50 Hz width. Spectral density was computed using the
Matlab periodogram method. Values were updated every 500 ms,
using 1-second-long rolling windows with 50% overlap. Real-time
spectral features derived from the 20 most neuromodulated
channels were averaged across channels to produce a single high
gamma band value for each 500 ms software update. Orthosis
hand-closure would be triggered by an increase in this mean
spectral power from the resting baseline ranging between 0.5 and
3 V2/Hz to values greater than 10 V2/Hz, where real-time values
above this threshold would make the hand motor close.

ARTICLE

Concomitant occupational and physical therapy. Since being
discharged from acute rehabilitation 60 days after the initial
stroke, the participant enrolled in outpatient physical and occupational therapy. Prior to the device implantation, the participant
completed a six-week course of occupational therapy screening
phase. Following device implantation, the participant continued
occupational therapy, twice per week, and physical therapy, once
per week, each session lasting approximately one hour. In the
three-month implantation phase, the participant hence received
24 one-hour sessions of occupational therapy and 12 one-hour
sessions of physical therapy. In addition, clinical trial assistants
practiced therapy exercises with the participant and accompanied
him to a gym for aerobic conditioning (either stationary bicycling
or NuStep combined arm and foot cycle, for 20 min to a target
heart rate of 120 beats per minutes): these sessions were
approximately one hour and were practiced daily, including
weekends for a total of 91 days. Occupational therapy focused on
postural training while seated and walking, donning, and dofﬁng
the MyoPro, repetitive trials of hand open/close elbow ﬂex/extend
wth the MyoPro, and using the MyoPro for functional activities.
Timed functional electrical stimulation26 (e.g., pincer grasp programs using the XCite brand FES unit from Restorative Therapies) and vibration therapy (5 to 10 min of focal muscle
vibration) were used for spasticity management27. Physical
therapy exercises included scapular mobilization, progressive
range of motion, weight bearing, forced use with game-related
activities to encourage left UE volitional control, and aerobic
endurance exercise. The exact exercises performed (passive and
active range of motion stretching, neuromuscular education,
electrical stimulation, orthosis use), blood pressure, and subjective
pain reports, were logged for every rehabilitation session; in
addition, clips of several sessions were recorded by video
(see Supplementary Occupational Therapy Log and Supplementary Videos 1–12 in particular Supplementary Video 12).
Reporting summary. Further information on research design is
available in the Nature Research Reporting Summary linked to
this article.
Results
The participant underwent intracortical implantation in autumn
of 2020 and explantation three months later on January 2021, in
accordance with the intended 3-month duration of the trial. Over
the course of the study, the participant had three minor, and one
serious, device-related adverse events, all of which were treated,
resolved, and reported to the governing regulatory bodies. The
serious adverse event was the development of a scalp infection at
the left pedestal site one week prior to the device removal date,
despite a regimen of topical antibiotics and regular cleaning. This
infection was anticipated and was described as a potential risk in
the informed consent form and consent interview. The left pedestal site had posed a challenge since the time of the initial surgery as it was not possible to exactly re-approximate the skin ﬂap
leaving the base of the pedestal exposed. This area was protected
and granulated and grew new skin. The participant was afebrile
and asymptomatic, and the infection was detected only by close
visual inspection. The participant was treated with twice daily
antibiotic for the 7 days prior to the device removal. Pedestal site
skin cultures taken at device removal revealed pansensitive staphylococcus lugdunesis and staphylococcus capitis, and yeast,
and appropriate antimicrobial treatment was provided. No
organisms grew from cultures taken of adjacent bone. The only
macroscopic evidence of infection at device removal was a small
area (~2 cm3) of erythema and friable tissue at the skin adjacent
to the right pedestal. Details of the surgical implantation and
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Fig. 3 Neuroimaging results. Diffusion sequence when the acute stroke occurred; diffusion restriction is evident in the right lentiform nucleus and adjacent
white matter (a). T2-weighted MRI two years later shows areas of encephalomalacia and relative ventriculomegaly (b). Functional neuroimaging revealed a
hot spot of activation, indicated by a red circle, in the depth of the central sulcus along the ‘hand knob’ area of the precentral gyrus (c). A three-dimensional
reconstruction of the participant’s cortical surface derived from MRI with imagined left hand movement centroid of activity indicated by the red circle (d).
Green shading indicates an area responsive to sensory stimulation of the left hand. Black squares indicate microelectrode arrays.

removal of the device is reported separately28. The participant
was discharged home. The participant remains in the Cortimo
trial for ongoing neurosurgical follow-up and surveillance, and to
track any further performance improvements in myoelectric
MyoPro use with ongoing outpatient occupational therapy.
Preoperative anatomic and functional neuroimaging. Preoperative imaging revealed the old infarct in right lentiform
nucleus and adjacent white matter including corona radiata and a
portion of the posterior limb of the internal capsule, along with a
large old right PCA infarct, progressed since the acute stroke
imaging MRI from 2019 (Fig. 3). In addition, a small region of
bandlike signal abnormality involving subcortical white matter
and medial aspect of hand knob region of right precentral gyrus
was identiﬁed, likely reﬂecting retrograde neuronal degeneration.
On DTI, there was extensive loss of fractional anisotropy in the
region of right corticospinal tract from old infarct. The imagined
left hand motor paradigm and passive motor paradigm were
diagnostic with good concordance. Subsequent to hypercapnia
challenge, a BOLD signal was evident at the precentral gyrus. On
the imagined left hand motor paradigm, activation was noted in
the expected location along central sulcus involving lateral aspect
of the hand knob region of the precentral gyrus and the adjacent
portion of postcentral gyrus (Fig. 3c). On the passive left elbow
motor paradigm, activation was seen along central sulcus which
shows good concordance with the imagined motor task as discussed with a slightly more posterior and superior extension of
activation reﬂecting the prominent sensory component of this
passive motor paradigm. A 3D brain model was printed using the
3D FLAIR sequence to allow for 3D visualization of the surgical
ﬁeld for more accurate pre-operative planning (Fig. 3d).
Neural recordings. Well-delineated single units were recorded
from 87 of the 256 channels (Fig. 4). Neural activity correlated
with actual and attempted movements in both the paretic left arm
in addition to the intact right arm. The discharge rate of various
units appeared to correlate with speciﬁc residual actions,
6

including the wrist extension that gradually developed in the
course of the three-month duration (Fig. 5). By taking the spike
counts recorded at each channel every 200 milliseconds and
running them through a leaky integrator29, and then summing
these leaky integrator outputs across all channels, we were able to
visualize the cumulative cross-array ﬁring rate activity in comparison to forearm electromyographic activity (Fig. 6, Supplementary Fig. 1). Of the 256 electrodes, in each session, we
identiﬁed 40 channels that were eventually used for neural
decoding. These channels were used for extraction of neural
features that coded for hand and elbow ﬂexion and extension.
Two main hand open-close decoding approaches were used: (1) A
discrete two-state classiﬁer based on a 1-dimensional linear ﬁlter
continuous output; (2) a training-less threshold crossing
approach with a rolling baseline normalization.
Orthosis control. The left upper extremity score on the Action
Research Arm Test (ARAT)19 was 0 without the orthosis on
measured at 1 month pre-implant and again at 3 months postimplant (Table 1). Three months-post-implant, the ARAT was 5
using the orthosis under myoelectric control, and 10 using the
orthosis under direct brain-control (myoelectric control was not
measured pre-implant because only a non-customized, less
comfortable version of the MyoPro was available for the introductory training period).
In one component of the Jebsen-Taylor standardized test of
hand function30, the goal is to pick up and move 5 cans, one at a
time, a few inches away forward on the table (normal times are
3.23 s for empty soup cans in subtest 6, and 3.30 s for full cans in
subtest 7). Because the design of the hand orthosis precluded the
ability to grasp a soup can (i.e., the brace only supports the thumb
and next two digits), the participant performed variations on the
test. It took the participant 146 s to pick up, move and release 5
pill bottles using the orthosis under myoelectric control, and 95 s
to perform the identical task using the orthosis under BCI control
(both performed on post-implant day 84). Another task was –
with the powered orthosis donned- to hold an object in the right
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Fig. 4 Action potential waveforms. Snapshot of action potential waveforms recorded from two of the arrays.
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Fig. 5 Neuronal activity correlated with performed movements in the paretic limb. Over a 110-s period, the participant was asked to perform a series of
left limb movements (described on abscissa). Verbal movement instructions indicated by hash marks. Rasters indicate the time of each action potential.
Normalized, integrated ﬁring rates appear beneath each raster, derived by a ‘leaky integrator’ eq. in29; normalization achieved by dividing by the maximum
integrated ﬁring rate from each unit’s spike train over the time period displayed. The top unit (channel 61) is more active for hand squeezing than wrist
extension, relative to the bottom, simultaneously recorded unit (channel 62). The participant performed all movements: such motions required effort and
he was unable to engage a consistent level of activity for each cue and exhibited a variable reaction time. The participant was easily fatigued, requiring him
to take a break and adjust posture. Numerical data that was used to generate this ﬁgure is available in Supplementary Data 2.
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Fig. 6 Cumulative, integrated spike activity across channels and simultaneous joint position and electromyographic activity. The integrated neural
activity ﬂuctuated with joint position and residual left forearm electromyographic activity. The summed spike activity across channels and run through a
leaky integrator29 (solid black line) appeared to ﬂuctuate with speciﬁc residual actions in the left upper extremity (a). Proximal residual activity generated a
normal appearing pattern as seen between 290 and 310 s, biceps (dashed light blue line) and triceps (solid dark blue line) activity alternate (b). In the distal
upper extremity, however, wrist ﬂexor (dashed gray line) and wrist extensor (solid gray line) activity, tend to occur simultaneous in an abnormal manner
(simultaneous agonist and antagonist contraction); also, wrist ﬂexor activity is abnormally synergistic with biceps activity (an abnormal ﬂexor synergy).
The summed, integrated spiking activity across channels (black line) appears to covary with wrist ﬂexor activity. Numerical data that was used to generate
this ﬁgure is available in Supplementary Data 2.

hand (e.g., a stress ball or a whiteboard eraser) and place it into
the paretic left hand, and then extend the left arm down towards
the ﬂoor and drop the object into a bin; this process was then
repeated 5 times in a row. Both these tasks were performed with
the participant seated. On two trials of this pick-up-and-drop-5
with the orthosis in myoelectric mode, the participant’s
completion times were 222 and 128 sec/trial (performed on
post-implant days 55 and 67, respectively); seconds; on ﬁve trials
of the same task in BCI mode, times were 81, 106, 137, 214 s
(post-implant days 48, 53, 55, 73). In addition to measuring the
total time to perform these grasp-move-release tasks, we also
quantiﬁed the time it took to release an object once the hand was
in the target position. In addition to the ﬁve-in-a-row trials, the
participant was also able to use the powered orthosis to perform
numerous other single or two to four-in-a-row of the same task.
Hand release times, while wearing the powered orthosis,
measured over multiple trials spanning multiple days of this
identical task were faster under BCI control than myoelectric
control (p = 0.04, two-sample t test; Table 2).
Unassisted motor outcomes. The following motor measures were
performed when the participant was not connected to the BCI and
was not wearing the MyoPro orthosis: Manual Muscle Testing,
8

Fugl-Meyer upper extremity score, Motricity Index, Stroke Impact
Scale, and the Modiﬁed Ashworth Scale (Tables 3, 4, Fig. 7, Supplementary Data 1). Collectively, these serial measures demonstrated that the implantation procedure did not decrease residual
strength in the paretic left arm and left leg. In fact, muscle strength
increased in the left arm. Whereas serial neurological exams (performed without the assistance of any device) since the time of the
stroke demonstrated an absence of voluntary wrist extension or
ﬁnger extension (0/5) on manual muscle testing, starting two
months into the trial, the participant began to consistently exhibit
voluntary wrist extension against gravity (3/5), and on a few
occasions was able to voluntarily extend the ﬁngers slightly (2/5)31.
The Motricity Index was 48 at one month pre-implant, 61.5 two
months post-implant, and 75.5 three months post-implant. One
month prior to the device implantation, the Fugl-Meyer upper
extremity score was 30 (out of a maximum of 66) for the left upper
extremity at baseline (one month pre-implant); this increased to a
score of 36 one month after the two Multiports were implanted, and
a score of 38 seven weeks post-implantation18 (it was not possible to
perform the Fugl-Meyer at exactly 8 weeks due to participant
fatigue and the logistics of occupational therapist availability). The
Stroke Impact Scale was 232 one month prior to implantation (the
scale ranges from 64 to 320 where higher numbers indicate better
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Table 1 Arm Research Action Test.

CONDITION
Block 10 cm3
Block 2.5 cm3
Block 5 cm3
Block 7.5 cm3
Cricket ball
Sharpening stone
Pour water from one glass to another
Displace 2.25-cm alloy tube from one side of table to the
other
Displace 1-cm allow tube from one side of table to other
Put washer over bolt
Ball bearing held between ring ﬁnger and thumb
Marble held between index ﬁnger and thumb
Ball bearing held between middle ﬁnger and thumb
Ball bearing held between index ﬁnger and thumb
Marble held between ring ﬁnger and thumb
Marble held between middle ﬁnger and thumb
Hand to behind the head
Hand to top of head
Hand to mouth
SUM

12 days (1.5 weeks) post-implant

10 weeks post-implant)

12 weeks post implant

NO BRACE
0
0
0
0
0
0
0
0

EMG-MYOPRO
0
1
0
0
0
1
0
1

BCI-MYOPRO
0
1
1
0
0
1
0
1

0
0
0
0
0
0
0
0
0
0
0
0

1
1
0
0
0
0
0
0
0
0
0
5

1
1
0
1
0
0
0
0
0
0
3
10

The participant was unable to perform any aspect of the test with the unassisted, paralyzed arm. Conditions performed with the assistance of the MyoPro powered orthosis, whether under myoelectric or
brain-computer interface control, are shown in non-italicized boldface. Conditions performed with the assistance of the MyoPro powered orthosis, only under brain-computer interface control, are shown
in italicized boldface.

Table 2 Object Release Times.
BCI Control
EMG Control

3 4 1 1 2 6 1 8 5 1 7 18 13 7 26 24 2 3 2 3 1 2 5
2 9 4 2 5 9 14 7 4 12
45 8 13 24 5 1 7 19 3 4

Hand release times measured in seconds over multiple trials spanning multiple days of this
identical task were faster under BCI control than myoelectric control (p = 0.04, two-sample
t test).

function; see Supplementary Data 1 for item-speciﬁc scores). Due to
coordination error, the Stroke Impact Scale was not recorded
during the implant phase; it was subsequently recorded six months
post-implant (three months post-explant) as 269. Although the
participant did not receive botulinum toxin injections, or receive
any type of anti-spasticity medication, during the clinical trial preoperative or implantation phase, spasticity gradually decreased with
time as reﬂected in gradually decreasing numbers on serial measurements of the modiﬁed Ashworth scale for spasticity for passive
ﬂexion and extension movements of the ﬁngers, wrist, and elbow,
along with internal and external rotation of the shoulder (Fig. 7)32.
In addition to the previously listed outcome measures that were
performed without any device assistance, the rectiﬁed root mean
square electromyographic activity was recorded by the MyoPro
sensors when the MyoPro was donned and in operation and
examples at various time points in the trial are shown in Supplementary Figs. 2–6; Supplementary Fig. 7 shows the time course of
principle components derived from the four time series (wrist
ﬂexors, wrist extensors, elbow ﬂexors, elbow extensors).
Discussion
This pilot trial demonstrated that ensemble single unit activity
remains active in ipsilesional cerebral cortex overlying chronic
subcortical stroke. To our knowledge, this is the ﬁrst report of
intracortical recordings in ipsilesional cerebral cortex for a stroke
above the mesencephalon. Although the corticospinal tract is also

affected in conditions such as brainstem stroke and ALS, in those
cases the underlying basal ganglia and other hemispheric motor
control circuitry are essentially intact. This proof-of-concept
study is important because it shows that an intracortical braincomputer interface approach is feasible in a class of stroke that is
far more common than brainstem stroke (or ALS) and indeed is
the leading cause of disability worldwide. The trial established
that single neuron, movement related activity can be decoded to
control a powered orthosis restoring functionally useful voluntary
upper extremity movement. Importantly, this brain-computer
interface system can be used simultaneously with residual intact
movement, in particular in a limb with a gradient of intact to
absent voluntary movement, as is common following cerebral
strokes. While myoelectric approaches based upon wrist ﬂexion
did enable voluntary hand opening, this approach triggered
increased muscle tone that subsequently slowed orthosis use (as
the motors were opposing the abnormal tone): the BCI control
mode essentially bypassed this issue and allowed motors to
operate more smoothly and quickly. Electromyographic recordings demonstrated that while the participant did continue to
engage wrist ﬂexors during BCI control, the amplitude was
decreased from abnormally elevated levels to more normal
amplitudes.
There are many other potential ways to activate an orthosis
other than using residual electromyographic activity at the wrist:
more proximal muscle activity (e.g., at the shoulder), contralateral
wrist activity11, contralesional scalp EEG13, inertial measurement
units to detect minute proximal movements, proximity detectors
(i.e., using RFID tags on objects to trigger the brace to open as it
approaches and then close once within a target distance or using
radar or other sensors mounted on the brace to detect proximity
to a target object), eye gaze, and even voice activation, represent
some of numerous alternative ways to peripherally activate
orthoses. This trial was about proving that useful signals could
be extracted from the stroke-affected hemisphere for controlling
the impaired arm. We assert that there is a distinction between
the arm passively following motors triggered by peripheral
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Table 3 Motricity Index, Fugl-Meyer, Stroke Impact Scale.
Motricity Index (without orthosis assistance)

One month preimplant
48
One month preimplant
30
One month preimplant
232

Fugl-Meyer Upper Extremity Score (without orthosis
assistance)
Stroke Impact Scale (without orthosis assistance)

Two months postimplant
61.5
One month post-implant
36

Three months post-implant
75.5
7 weeks post-implant
38
Six months post-implant (three months
post-explant)
269

Table 4 Manual Muscle Testing.
Manual Muscle
Testing

15 months
pre-implant

Finger ﬂexion
Finger extension
Wrist extension
0
Wrist ﬂexion
3
Elbow extension 2
triceps
Elbow
1
ﬂexion biceps
Shoulder abduction
Shoulder adduction

3
3
4

3
0
2
2
4

3

4

3

11 weeks,
3 days postimplant
3

3
5
5

3
0
3
3
5

5

5

5

4

4
5

7 weeks
postimplant

0
1
0

0
0
0
0
4

0
0
0
0
4

1

5
5
5

10 weeks
post-implant

3 days
postexplant

Day of explant
(pre-op)
3 months postimplant
4
0
1
3
2

11 weeks
postimplant

Day of
implant
(pre-op)

8 months
pre-implant

4
5

1

3

0

2

Shoulder internal rotation

2

0

0

Finger flexion

Wrist flexion

0

4

Elbow flexion
Shoulder external rotation
3

0

Finger extension
1

Wrist extension
3

Elbow extension
3

0

2
3 months

Fig. 7 Modiﬁed Ashworth Scale variation across time. The Modiﬁed Ashworth Scale ranges from 0 (normal) to 4, most spastic. These measurements
were recorded serially over the three-month implantation phase and are shown graphically. Qualitatively, spasticity appeared to gradually decrease during
this duration. Numerical data that was used to generate this ﬁgure is available in Supplementary Data 2.

sensors, versus closing the brain circuitry loop while the brain is
trying to control the arm and the arm is moving. Even though of
course peripheral triggers are ultimately also controlled by the
brain, homing in on the actual substrate of motor control that
previously had coordinated the paretic limb is presumed to
exercise a plasticity that cannot be achieved by using substitute
signals. The trial’s demonstration justiﬁes further exploration of
motor neocortex, that has been disconnected by a subcortical
stroke, as a control signal source, even if alternate peripheral
modes of control exist. Indeed, it may be that a principled
combination of control modes would provide patients the greatest
potential for recovery.
This trial was not intended to restore voluntary motor control
in the hemiparetic upper extremity in the absence of any device
10

use, but even so, we found that strength improved, and spasticity
decreased in the native, paretic arm when BCI control was not in
use. This suggests that the implantation of four arrays into ipsilesional cortex did not exacerbate pre-existing hemiparesis (i.e., it
did not worsen hand or arm weakness); indeed, after the intervention hand functions improved. One potential explanation for
the unexpected improvements in voluntary wrist and ﬁnger
extension is mass practice. Another, more speculative, explanation for the participant’s improved forearm function is that the
daily exercise of ipsilesional cortical activity for BCI-orthosis
control, promoted a plasticity driven response to either normalize
or compensate for abnormal motor synergies.
There were several limitations in this study. It was of only one
participant, only took place over a brief duration (three months),
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and outcome measures could not be tested repeatedly. Most of the
predetermined outcome measures (e.g., Fugl-Meyer, Motricity
Index), by their nature cannot disambiguate the effects of different control modes on voluntary upper extremity use from nonspeciﬁc rehabilitation effects. The one measure that could- the
ARAT- was difﬁcult in practice to perform due to the way the
MyoPro hand piece clasped objects and the fact that the participant had to be tethered when the cables were plugged in. It was
for this reason that the Jebsen-Taylor move-5-objects task
was added.
Although the limited number of trials on various tasks reduced
statistical power to compare myoelectric to BCI control, qualitatively there appeared to be a trend of faster control in the BCI
mode. This may be because triggering orthosis action from direct
cortical recordings does not activate abnormal forearm synergies
in the same manner that myoelectric control appears to. Spasticity may represent abnormal plasticity and loss of corticoreticular
facilitation of the medullary inhibition center leading to decreased
inhibition from the dorsal reticulospinal tract on the spinal
stretch reﬂex: the medial reticulospinal and vestibulospinal tracts
are unopposed leading to stretch reﬂex hyperexcitability33. In the
myoelectric mode, where hand closing is triggered by activation
of residual wrist ﬂexors, this hyperexcitability is inevitably triggered such that the orthosis motors must ﬁght harder to open the
hand, slowing that process. In the BCI mode, even if residual
wrist ﬂexor and extensor activity are engaged, it is to a lesser
degree such that abnormal tone is not elevated, and the orthosis
motors can more easily and rapidly achieve hand actions.
This pilot study implies that usable control signals are present
in ipsilesional cerebral cortical activity. To be clinically scalable,
future devices must be fully implantable to minimize infection
risk and allow mobility. With the advent of fully implantable BCI
(i.e., no percutaneous connectors34–36), a wider range of stroke
survivors could beneﬁt: in particular, this demonstration that
usable control signals can be derived after a subcortical stroke
affecting the corticospinal tract (coursing through the corona
radiata) is more relevant to a wider number of people than what
may be inferred in less common brainstem stroke where the
supratentorial cerebral machinery of motor control typically
remains intact. An option that may gain even wider clinical
adoption would be to couple direct cortical control to implantable
functional electrical stimulation in the paretic arm, the latter
having been demonstrated in at least one person with chronic
stroke10. Direct cortically driven peripheral muscular stimulation
may have both rehabilitative37 and direct functional beneﬁts if
deployed continuously in daily life. Fully implantable braincomputer interfaces (Fig. 8) may represent a medical device
opportunity to help stroke patients break through their plateau in
recovery and to achieve greater functional independence.
Previous work has demonstrated that motor cortex can continue to represent movements even years after injury has caused
paralysis, such as deduced from intracortical recording in people
with spinal cord injury38, or fMRI in a person with a limb that
has been amputated39. In hemispheric stroke, electromyographically triggered functional electrical stimulation in the
paretic limb can activate and enhance the function of the ipsilesional residual corticospinal tract40.
We do not assert that implantable electrodes are the only or
best control mode compared to alternative ways to peripherally
activate orthoses: in this study, the participant served as his own
control in that the orthosis was controlled by either peripheral
myoelectric activity or central cortical activity. We anticipate that
in many, and perhaps most, people with hemiplegic stroke that
peripheral activity (e.g., inertial measurements) may sufﬁce for
orthosis control: what this current study adds is that direct central
recording can also serve as a control signal source if peripheral

sources are not adequate, or indeed both types of signals could be
combined. If intact substrate for motor control exists “on the
other side” of a subcortical stroke, then deploying this substrate to
reinstantiate control may afford an advantage over using peripheral signals that ultimately are a substitute.
The improvement that chronic stroke patients may achieve
with mass practice (5 h per day, 5 days per week for 1241,42),
raises the question of whether an invasive approach were justiﬁed.
We propose that the advantage of functional restoration is that
the world can be the person’s rehabilitation: in other words, the
person can do the rehabilitation while doing what they want to
do, rather than spending hours to days every week at a rehabilitation gym. In other words, every day accumulates into mass
practice and real life is rehabilitation. There are individuals with
severe hemiparesis after stroke who do not regain any function
even with rehabilitation (e.g., passive range of motion, stretching
exercises, muscle stimulation). For this population in particular, a
BCI electrical bypass could present an opportunity to regain some
functional movement43. Such restoration would most likely be
assistive in nature- namely any movement gain would cease when
the BCI were not in operation. If in fact motor gains were to
persist even when the BCI were turned off—implying that its use
had achieved a rehabilitation effect on residual endogenous circuitry—that would suggest considerably more latent restoration
potential were present after severe stroke than were currently
known. If that were to be found, it might recast the use of
implantable BCI as a temporary, reversible intervention to

Wireless
relay

Implanted
functional
electrical
stimulator

Fig. 8 A hypothetical fully implantable upper extremity movement
restoration system for people with hemiparesis from chronic stroke.
Sensors implanted within or adjacent to perilesional motor cortices relay
signals wirelessly to microprocessors that decode motor intent that in turn
triggers a functional electrical stimulation system implanted within the
paretic limb to restore voluntary motor function.
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unmask rehabilitation potential- analogous to myocardial recovery in certain with patients left ventricular assist devices that
persist even after the device is removed44.
Although wearable and implantable medical devices offer one
approach to restoring motor function after stroke, stem cell45
and surgical approaches also show promise. Surgical transfer of
the C7 nerve from the nonparalyzed side to the side of the arm
that was paralyzed, in adults with chronic brain injury including
stroke, has been shown to yield greater improvements in function and reduction of spasticity than rehabilitation alone over a
period of 12 months, when quantiﬁed by Fugl-Meyer and
Modiﬁed Ashworth Scale measures46. In effect, this transfer
approach enables a person to use the motor cortex in the intact
hemisphere to achieve movement in the otherwise paralyzed
limb. What that approach and the one described in this report
have in common is that they both use of multi-modality therapy
(e.g., passive and active exercise, physical and occupational
therapy, orthoses) to leverage the person’s remaining ability to
learn. The approaches differ not only by the physical modality
(cervical root transfer versus cortical device implant-powered
orthosis), but by the areas of the brain they leverage, with the
intracortical neuroprosthetic inducing a kind of exercise of the
neocortex overlying the chronic stroke. In both cases, the
putative mechanisms of spasticity are not directly targeted (e.g.,
unopposed reticulospinal and rubrospinal tone), yet both have
the potential to reduce spasticity, even though in the cervical
root transfer the paralyzed limb is being activated in a more
natural manner than a powered orthosis pulling the limb into
the desired position. Future investigation will be needed to
clarify the relative beneﬁts of each approach and the possibility
of combining them together to aspire to an even greater
recovery possible than one approach alone.
Ongoing progress in fully implantable multi-channel
recording systems (whether subdural grids47–49, intracortical
microelectrodes35,50 or endovascular electrodes51,52) to derive a
control signal, and in fully implantable effector systems (whether implanted functional electrical stimulation, peripheral
nerve cuffs, or epidural spinal stimulators), gives hope that the
approach outlined in this report could be distilled into a
modular medical device to address the leading cause of disability worldwide. Whether brain-computer interfaces to treat
stroke are assistive in the sense that, like cochlear implants,
their beneﬁts accrue only when in operation, or are more like
left ventricular assist devices, where continual use potentiates
recovery in damaged structures in a rehabilitative manner that
can outlast device operation, is a question that will require
further research to address. We anticipate that there will be a
distribution of patients such that for some, the device would be
purely functional, and beneﬁts would cease the moment the
device were disengaged, and that for others, regular device
might induce Hebbian plasticity and homeostatic mechanisms
centrally and build muscle bulk and improve connective tissue
peripherally in a manner that would persist even when the
device were not in operation. Either outcome would represent
an advance for medical science, and an opportunity for people
living with stroke to not just break through the plateau of
functional recovery, but to maintain those gains continually in
daily life.

Code availability
Custom code created for this study is freely available in an online repository54: https://
doi.org/10.5281/zenodo.5885015.
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